-
Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery.
Sharabi-Nov A, Kumar K, Fabjan Vodušek V, Premru Sršen T, Tul N, Fabjan T, Meiri H, Nicolaides KH, Osredkar J.
Fetal Diagn Ther 2020;47:471-484. pdf -
Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia.
Lai J, Pinas A, Syngelaki A, Poon LC, Nicolaides KH.
J Matern Fetal Neonatal Med 2013;26:733-7. -
Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11-13 weeks.
Beta J, Akolekar R, Ventura W, Syngelaki A, Nicolaides KH.
Prenat Diagn 2011;31:75-83. -
Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks.
Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH.
Prenat Diagn 2011;31:66-74. -
Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Minekawa R, Veduta A, Romero XC, Nicolaides KH.
Prenat Diagn 2009;29:753-60. -
Maternal serum activin at 11-13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Etchegaray A, Zhou Y, Maiz N, Nicolaides KH.
Fetal Diagn Ther 2009;25:320-7. -
Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K, Cowans NJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:622-6. -
Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis.
Yu CKh, Casas JP, Savvidou MD, Sahemey MK, Nicolaides KH, Hingorani AD.
BMC Pregnancy Childbirth 2006;6:7. -
First trimester sex hormone-binding globulin and subsequent development of preeclampsia or other adverse pregnancy outcomes.
Spencer K, Yu CK, Rembouskos G, Bindra R, Nicolaides KH.
Hypertens Pregnancy 2005;24:303-11. -
First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY, Liao AW, Munim S, Spencer K, Nicolaides KH.
J Matern Fetal Neonatal Med 2004;15:176-80. -
Maternal serum activin A and inhibin A in trisomy 18 pregnancies at 10-14 weeks.
Spencer K, Liao AW, Ong CY, Flack NJ, Nicolaides KH.
Prenat Diagn 2001;21:571-4. -
Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester.
Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH.
Prenat Diagn 2001;21:441-4. -
Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies.
Spencer K, Liao AW, Skentou H, Ong CY, Nicolaides KH.
Prenat Diagn 2001;21:270-3. -
Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy.
Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD.
Hypertension 2001;38:1289-93. -
Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre-eclampsia.
Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH.
BJOG 2000;107:795-7. -
Maternal serum inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10-14 weeks of gestation.
Noble PL, Wallace EM, Snijders RJ, Groome NP, Nicolaides KH.
BJOG 1997;104:367-71. -
Exhaled nitric oxide concentration and amniotic fluid nitrite concentration during pregnancy.
Morris-NH, Carroll S, Nicolaides KH, Steer PJ, Warren JB.
Eur J Clin Invest 1995;25:138-41.